Connect with us


More Vaccines For Africa as Aspen in Talks With J&J to Increase Africa Vaccine Production



Vaccines inequality continues with advanced economies getting the biggest part of the pie and many African Nations left largely unvaccinated. This might change as Aspen Pharmacare Holdings Ltd. is in talks with Johnson & Johnson to increase production of Covid-19 vaccines and evaluate a potential license for Africa’s biggest drugmaker, positioning itself for further developments in the inoculation sphere.

The discussions are underway as the African Union and European Union look to bolster the supply of coronavirus vaccines to the continent, and could extend an existing agreement for Aspen to package and fill vials of the U.S. company’s vaccine at a plant in South Africa.


Sign up for our Newsletter

Enter your email and stay on top of things,